MB
WVE icon

MPM BioImpact’s Wave Life Sciences WVE Stock Holding History

MPM BioImpact’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,505,262
Closed -$11M – 53
2025
Q3 		$11M Hold
1,505,262
– – 1.8% 26
2025
Q2 		$9.78M Sell
1,505,262
-4,318
-0.3% -$28.5K 1.7% 26
2025
Q1 		$12.2M Buy
1,509,580
+20,343
+1% +$222K 2.1% 18
2024
Q4 		$18.4M Buy
1,489,237
+864,766
+138% +$11.5M 2.62% 13
2024
Q3 		$5.12M Buy
+624,471
New +$3.73M 0.77% 35

Other funds holding WVE

GP
GSK plc London $602M AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

MPM BioImpact's WVE Position: Q4 2025 in Review

MPM BioImpact sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 1,505,262 shares — an estimated $11M sold.

MPM BioImpact first reported a position in WVE in Q3 2024 and held it in 5 quarters. The position peaked at $18.4M in Q4 2024. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • MPM BioImpact reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • MPM BioImpact sold 1,505,262 Wave Life Sciences shares in Q4 2025, an estimated $11M.
  • MPM BioImpact first reported a position in Wave Life Sciences in Q3 2024 and held it in 5 quarters.
  • MPM BioImpact's Wave Life Sciences position peaked at $18.4M in Q4 2024.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on MPM BioImpact's 13F filing for Q4 2025, filed 17 Feb 2026.